Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

First Affiliated Hospital Of Wenzhou Medical University

Clinical trials sponsored by First Affiliated Hospital Of Wenzhou Medical University, explained in plain language.

Trials to join now! 5 Not yet recruiting 18 Not yet finished but already full! 1 Completed 2

Could a cancer drug slow lung scarring? new trial tests anlotinib for IPF

Disease control Ongoing

This Phase 2 trial tests whether anlotinib, a drug currently used for cancer, can help people with idiopathic pulmonary fibrosis (IPF) or progressive fibrosis-interstitial lung disease. The study involves 30 adults aged 40-85 and measures changes in lung function over 52 weeks. P…

Phase: PHASE2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control

Last updated Jun 27, 2026 13:03 UTC